Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q1 CY2026, ...

In the past quarter, McKesson Corporation reported fourth-quarter fiscal 2026 sales of US$96.30 billion and net income of US$1.68 billion, with full-year sales reaching US$403.43 billion and net ...

McKesson (MCK) came out with quarterly earnings of $11.69 per share, beating the Zacks Consensus Estimate of $11.56 per share. This compares to earnings of $10.12 per share a year ago. These figures ...

McKesson (MCK) reported $96.3 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 6%. EPS of $11.69 for the same period compares to $10.12 a year ago. The ...

Investors in McKesson Corp (Symbol: MCK) saw new options begin trading today, for the March 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MCK options ...

Much of MCK's recent growth stems from high-priced drugs and GLP-1 revenues, which may plateau and expose underlying business ...

McKesson Corporation (NYSE:MCK) will release its fourth-quarter financial results after the closing bell on Thursday. Analysts expect the company to report quarterly earnings at $9.83 per share, up ...

McKesson, Inc. (MCK) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. Order flow analytics, ...

McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic about the company’s performance in 2025. MCK’s growth this year will be ...